B. Riley analyst John Massocca raised the firm's price target on Diversified Healthcare Trust to $6.50 from $5.50 and keeps a Buy rating on the shares. Despite the recent shift of $25.8M of planned dispositions to 1Q26, the firm remains confident Diversified Healthcare Trust will have ample liquidity to address January zero-coupon debt maturity, the analyst tells investors in a research note.
